Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-β: Contrasting effects of anti-CD2 and anti-CD3

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2248-2254

  Gray, J Dixon ^a   Hirokawa, Makoto ^a,b   Ohtsuka, Kazuo ^a   Horwitz, David A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MINK; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032030619     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Meur, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdnon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T cell activation: a functional role for the 50KD T11 sheep erythrocyte receptor protein. Cell 36:897.
2. Moingeon, P., H.-C. Chang, P. H. Sayre, L. K. Clayton, A. Alcover, P. Gardner, and E. L. Reinherz. 1989. The structural biology of CD2. Immunol. Rev. 111:111.
3. Bierer, B. E., B. P. Sleckman, S. E. Ratnofsky, and S. J. Burakoff. 1989. The biologic roles of CD2, CD4 and CD8 in T cell activation. Annu. Rev. Immunol. 7:579.
4. Hahn, W. C., Y. Rosenstein, V. Calvo, S. J. Burakoff, and B. E. Bierer. 1992. A distinct cytoplasmic domain of CD2 regulates ligand avidity and T-cell responsiveness to antigen. Proc. Natl. Acad. Sci. USA 89:7179.
5. Suthanthiran, M. 1990. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen. J. Exp. Med. 171:1965.
6. Yssel, J., J. P. Aubry, R. de Waal Malefijt, J. E. de Vries, and H. Spits. 1987. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. J. Immunol. 139: 2850.
7. Stohl, W., and M. K. Crow. 1990. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Cell. Immunol. 130:257.
8. Chavin, K. D., H. T. Lau, and J. S. Bromberg. 1992. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 54:286.
9. Jung, S., K. Toyka, and H. P. Hartung. 1995. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Eur. J. Immunol. 25:1391.
10. Guckel, B., C. Berek, M. Lutz, P. Altevogt, V. Schirrmacher, and B. A. Kyewski. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174:957.
11. Chavin, K. D., L. Qin, R. Yon, J. Lin, H. Yagita, and J. S. Bromberg. 1994. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade. J. Immunol. 152:3729.
12. Stohl, W., D. N. Posnett, and N. Chiorazzi. 1987. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J. Immunol. 138:1667.
13. Hirohata, S., D. F. Jelinek, and P. E. Lipsky. 1988. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J. Immunol. 140:3726.
14. Gray, J. D., M. Hirokawa, and D. A. Horwitz. 1994. The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T cells and NK cells. J. Exp. Med. 180:1937.
15. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and B. De Crombruggehe. 1987. Some recent advances in the chemistry and biology of TGFβ. J. Cell Biol. 105: 1039.
16. Wahl, S. M. 1994. Transforming growth factor β: the good, the bad and ugly. J. Exp. Med. 180:1587.
17. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
18. Lee, H. M., and S. Rich. 1993. Differential activation of CD8+ T cells by transforming growth factor β1. J. Immunol. 151:668.
19. de Jong, R., R. A. van Lier, F. W. Ruscetti, C. Schmitt, P. Debre, and M. D. Mossalayi. 1994. differential effect of transforming growth factor-β1 on the activation of human naive and memory CD4+ T lymphocytes. Int. Immunol. 6:631.
20. Flaumenhaft, R., S. Kojima, M. Abe, and D. B. Rifkin. 1993. Activation of latent transforming growth factor β. Adv. Pharmacol. 24:51.
21. Zarling, J. M., K. A. Clouse, W. E. Biddison, and P. C. Kung. 1981. Phenotypes of human natural killer cell populations detected with monoclonal antibodies. J. Immunol. 127:2575.
22. - LGL function. Eur. Cytokine Netw. 2:31.
23. Morreta, A., E. Ciccone, G. Tambussi, C. Bottino, O. Viale, D. Pende, A. Santoni, and M. C. Mingari. 1989. Surface molecules involved in CD3-negative NK cell function. Int. J. Cancer 4:48.
24. Uggla, C. K., M. Geisberg, M. Jondal, and R. W. Knowles. 1989. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing. Scand. J. Immunol. 29:507.
25. Denholm, E. M., and F. M. Wolber. 1991. A simple method for the purification of human peripheral blood monocytes. J. Immunol. Methods 144:247.
26. Abrams, S. I., and Z. Brahmi. 1988. Mechanism of K562-induced human natural killer cell activation using highly enriched effector cells isolated via a new single-step sheep erythrocyte assay. Ann. Inst. Pasteur Immunol. 139:361.
27. Huet, S., J. Wakasugi, G. Sterkers, J. Gilmour, T. Tursz, L. Boumsell, and A. Bernard. 1986. T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J. Immunol. 137:1420.
28. Stohl, W., D. N. Posnett. and N. Chiorazzi. 1987. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J. Immunol. 138:1667.
29. Fleit, H. B., S. D. Wright, and J. C. Unkeless. 1982. Human neutrophil Fcγ receptor distribution and structure. Proc. Natl. Acad. Sci. USA 79:3275.
30. Hirokawa, M., J. D. Gray, T. Takahashi, and D. A. Horwitz. 1992. Human resting B lymphocytes serve as accessory cells for anti-CD2 induced T cell activation. J. Immunol. 149:1859.
31. 2-macroglobulin. J. Biol. Chem. 262:14090.
32. Stach, R. M., and D. A. Rowley. 1993. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated antigens. J. Exp. Med. 178:841.
33. Abe, M., J. G. Harpel, C. N. Metz, I. Nunes, D. J. Loskutoff, and D. B. Rifkin. 1994. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter luciferase construct. Anal. Biochem. 216:276.
34. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020.
35. Morimoto, C., T. Matsuyama, C. E. Rudd, A. Forsgren, N. L. Letvin, S. and F. Schlossman. 1988. Role of the 2H4 molecule in the activation of suppressor inducer function. Eur. J. Immunol. 18:731.
36. + inducer T cell subpopulation. Cell. Immunol. 133:367.
37. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and B. De Crombrugghe. 1987. Some recent advances in the chemistry and biology of TGFβ. J. Cell Biol. 105: 1039.
38. Sato, Y. R. Tsuboi, R. Lyons, H. Moses, and D. B. Rifkin. 1990. Characterization of the activation of latent TGFβ by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self regulating system. J. Cell Biol. 111:757.
39. Atonelli-Orlidge, A., K. B. Saunders, S. R. Smith, and P. A. D'Amore. 1989. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86:4544.
40. Nunes I., R. L. Shapiro, and D. B. Rifkin. 1995. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155:1450.
41. Goldfarb, R. H., T. Timonen, and R. B. Herberman. 1984. Production of plasminogen activator by human natural killer cells. J. Exp. Med. 159:935.
42. Nykjaer A., C. M. Petersen, B. Moller, P. A. Andreasen, and J. Gliemann. 1992. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells. FEBS 300:13.
43. Kehrl, J. H. 1991. Transforming growth factor-β: an important mediator of immunoregulation. Int. J. Cell Cloning 9:438.
44. Ruscetti, F., L. Varesio, A. Ochoa, and J. Ortaldo. 1993. Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann. NY Acad. Sci. 685:488.
45. + suppressors of human B cell responsiveness. J. Immunol. 142:3104.
46. Fast, L. D. 1992. Generation and characterization of IL-2-activated veto cells. J. Immunol. 149:1510.
47. + suppressor inducer cells. J. Immunol. 145:2854.
48. Fox, F. E., H. C. Ford, R. Douglas, S Cherian, and P. C. Nowell. 1993. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150:45.
49. + suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J. Immunol. 150:2121.
50. Blazar, B. R., P. A. Taylor, and D. A. Vallera. 1994. In vivo or in vitro anti-CD3 ∈ chain monoclonal antibody therapy for the prevention of lethal murine graft versus host disease across the major histocompatibility barrier in mice. J. Immunol. 152:3665.
51. Woodley, S. L., K. E. Gurley, S. L. Hoffmann, M. R. Nicolls, R. Hagberg, C. Clayberger, B. Holm, X. Wang, B. M. Hall, and S. Strober. 1993. Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies. Transplantation 55:1443.
52. Ferran, C., K. Sheehan, M. Dy, R. Schreiber, S. Merite, P. Landais, L. H. Noel, G. Grau, J. Bluestone, J. F. Bach, and L. Chatenoud. 1990. Cytokine related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient T cell activation. Eur. J. Immunol. 20:509.
53. Ferran, C., M. Dy, K. Sheehan, S. Merite, R. Schreiber, P. Landais G. Grau, J. Bluestone, J. F. Bach, and L. Chatenoud. 1991. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin. Exp. Immunol. 86:537.
54. Alegre, M. P. Vandenabeele, V. Flamand, M. Moser, O. Leo, D. Abramowicz, J. Urbain, W. Fiers, and M. Goldman. 1990. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur. J. Immunol. 20:707.
55. Bockenstedt, L. K., M. A. Goldsmith, M. Dustin, D. Olive, T. A. Springer, and A. Weiss. 1988. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J. Immunol. 141:1904.
56. Miller, G. T., P. S. Hochman, W. Meier, R. Tizard, S. A. Bixler, M. D. Rosa, and B. P. Wallner. 1993. Specific interaction of lymphocyte function-associated antisen 3 with CD2 can inhibit T cell responses. J. Exp. Med. 178:211.
57. Kos, F. J., and E. G. Engleman. 1995. Requirement for natural killer cells in the induction of cytotoxic T cells. J. Immunol. 155:578.
58. Kondo, S., K. Isobe, N. Ishiguro, I. Nakashima, and T. Miura. 1993. Transforming growth factor-β1 enhances the generation of allospecific cytotoxic T lymphocytes. Immunol. 79:459.
59. Van Tol, E. A., H. W. Verspaget, A. S. Pena, C. V. Kraemer, and C. B. Lamers. 1992. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria. Eur. J. Immunol. 22:23.
60. Lauzon, W., and I. Lemaire. 1994. Alveolar macrophage inhibition of lung-associated NK activity: involvement of prostaglandins and transforming growth factor-β1. Exp. Lung Res. 20:331.
61. Starkey, P. M., I. L. Sargent, and C. W. G. Redman. 1988. Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 65:129.
62. Broder, W. A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1.
63. Barnard, J. A., G. J. Warwick, and L. I. Gold. 1993. Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology 105:67.
64. Roelen, B. A. J., H. Y. Lin, V. Knezevic, E. Freund, and C. L. Mummery. 1994. Expression of TGFβs and their receptors during implantation and organogenesis of the mouse embryo. Dev. Biol. 166:716.
65. Coffman, R. L., D. A. Lebman, and B. Shrader. 1989. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039.
66. van Vlasselaer, P., J. Punnonen, and J. E. de Vries. 1992. Transforming growth factor-β directs IgA switching in human B cells. J. Immunol. 148:2062.
67. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. al-Sabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
68. Strober, W., B. Kelsall, I. Fuss, T. Marth, B. Ludviksson, R. Ehrhardt, and M. Neurath. 1997. Reciprocal IFNγ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today 18:61.